Disease Susceptibility: Clinical Trials

5 trials for Disease Susceptibility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1

Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment
Torasemide, Spironolactone - Hypertension, Genetic Predisposition
Phase 3CompletedOspedale San Raffaele382021-02-152024-05-16
Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
DT group, ET group, NX group - Susceptibility, Genetic, Chemotherapy Effect
Phase 3UnknownTianjin Medical University Cancer Institute and Hospital3002017-12-012017-12-02
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
Cloxacilin, Cloxacillin, Levofloxacin - Staphylococcus
Phase 3TerminatedFundación Pública Andaluza Progreso y Salud12013-05-012015-08-07
Prevention of Obesity in Women Via Estradiol Regulation
leuprolide acetate, Estradiol Transdermal, progressive resistance exercise training - Obesity
Phase 3CompletedUniversity of Colorado, Denver792008-05-012025-04-01
Secondary Prevention of Osteoporosis
alendronate with cholecalciferol, calcium carbonate with cholecalciferol, Falls prevention measures - Osteoporosis
Phase 3CompletedHebrew SeniorLife292007-02-012020-02-05

Narrower conditions

Genetic Predisposition to Disease (2)  ·  Breast Neoplasms (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Osteoporosis (1)  ·  Osteoporotic Fractures (1)  ·  Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities (1)

Broader conditions

Disease Attributes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Body Weight (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Breast Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Fractures, Bone (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Insulin Resistance (1)

Interventions

Alendronate (1)  ·  Calcium Carbonate (1)  ·  Canrenoic Acid (1)  ·  Capecitabine (1)  ·  Cholecalciferol (1)  ·  Cloxacillin (1)  ·  Docetaxel (1)  ·  Estradiol (1)  ·  Fumigant 93 (1)  ·  Leuprolide (1)  ·  Levofloxacin (1)  ·  Spironolactone (1)  ·  Torsemide (1)  ·  Vinorelbine (1)  ·  liposomal doxorubicin (1)

Sponsors

Fundación Pública Andaluza Progreso y Salud (1)  ·  Hebrew SeniorLife (1)  ·  Ospedale San Raffaele (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)  ·  China (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Jin Zhang, Doctor (1)  ·  Paolo Manunta, MD (1)  ·  Sarah D Berry, MD, MPH (1)  ·  Wendy M Kohrt, PhD (1)

Results publications

PMID 29631362

NIH funding

R01AG018198 (1), T32AG023480 (1)